Morio Ohtsuka

1.9k total citations
110 papers, 1.4k citations indexed

About

Morio Ohtsuka is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Morio Ohtsuka has authored 110 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Pulmonary and Respiratory Medicine, 40 papers in Oncology and 25 papers in Surgery. Recurrent topics in Morio Ohtsuka's work include Lung Cancer Research Studies (19 papers), Lung Cancer Diagnosis and Treatment (18 papers) and Lung Cancer Treatments and Mutations (18 papers). Morio Ohtsuka is often cited by papers focused on Lung Cancer Research Studies (19 papers), Lung Cancer Diagnosis and Treatment (18 papers) and Lung Cancer Treatments and Mutations (18 papers). Morio Ohtsuka collaborates with scholars based in Japan, United States and Russia. Morio Ohtsuka's co-authors include Hiroaki Satoh, Hiroichi Ishikawa, Kiyohisa Sekizawa, Koichi Kurishima, Katsunori Kagohashi, Shizuo Hasegawa, Hiroshi Kamma, Yukio Ishii, Tohru Sakamoto and Akihiro Nomura and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Journal of the American Geriatrics Society.

In The Last Decade

Morio Ohtsuka

105 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morio Ohtsuka Japan 20 887 362 235 232 204 110 1.4k
Masahiro Tominaga Japan 23 541 0.6× 401 1.1× 239 1.0× 931 4.0× 148 0.7× 127 1.6k
Kimo C. Stine United States 22 332 0.4× 315 0.9× 91 0.4× 243 1.0× 323 1.6× 59 1.4k
Jiro Usuki Japan 19 1.0k 1.2× 181 0.5× 282 1.2× 148 0.6× 242 1.2× 44 1.6k
David G. Morris United States 13 950 1.1× 136 0.4× 97 0.4× 131 0.6× 397 1.9× 17 1.6k
B Gosselin France 17 730 0.8× 111 0.3× 158 0.7× 189 0.8× 156 0.8× 49 1.3k
Anne Marfaing‐Koka France 19 528 0.6× 311 0.9× 134 0.6× 381 1.6× 182 0.9× 34 1.7k
Marie‐Noelle Péraldi France 23 309 0.3× 438 1.2× 400 1.7× 327 1.4× 217 1.1× 51 1.6k
Koichiro Nakata Japan 17 1.3k 1.5× 159 0.4× 304 1.3× 96 0.4× 113 0.6× 57 1.6k
M.C. Copin France 17 437 0.5× 259 0.7× 67 0.3× 294 1.3× 172 0.8× 42 1.1k
Y Fukuda Japan 12 746 0.8× 138 0.4× 79 0.3× 250 1.1× 166 0.8× 39 1.1k

Countries citing papers authored by Morio Ohtsuka

Since Specialization
Citations

This map shows the geographic impact of Morio Ohtsuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morio Ohtsuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morio Ohtsuka more than expected).

Fields of papers citing papers by Morio Ohtsuka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morio Ohtsuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morio Ohtsuka. The network helps show where Morio Ohtsuka may publish in the future.

Co-authorship network of co-authors of Morio Ohtsuka

This figure shows the co-authorship network connecting the top 25 collaborators of Morio Ohtsuka. A scholar is included among the top collaborators of Morio Ohtsuka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morio Ohtsuka. Morio Ohtsuka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nosaki, Shohei & Morio Ohtsuka. (2025). The DNA binding of plant-specific GROWTH-REGULATING FACTOR transcription factors is stabilized by GRF-INTERACTING FACTOR coactivators. Bioscience Biotechnology and Biochemistry. 89(5). 761–768. 2 indexed citations
2.
Satoh, Hiroaki, Hiroichi Ishikawa, Gen Ohara, et al.. (2008). Long-term survivors after chemotherapy in advanced non-small cell lung cancer.. PubMed. 27(6C). 4457–60. 23 indexed citations
3.
Satoh, Hiroaki, et al.. (2007). Psychotropic drugs for terminally ill patients with respiratory disease.. PubMed. 55(1). 5–10. 2 indexed citations
4.
Matsuno, Yosuke, Yukio Ishii, Keigyou Yoh, et al.. (2007). Overexpression of GATA-3 Protects against the Development of Hypersensitivity Pneumonitis. American Journal of Respiratory and Critical Care Medicine. 176(10). 1015–1025. 18 indexed citations
5.
Kodama, Takahide, Hiroaki Satoh, Hiroichi Ishikawa, & Morio Ohtsuka. (2007). Serum Levels of CA19‐9 in patients with nonmalignant respiratory diseases. Journal of Clinical Laboratory Analysis. 21(2). 103–106. 58 indexed citations
6.
Kagohashi, Katsunori, Hiroaki Satoh, Koichi Kurishima, Hiroichi Ishikawa, & Morio Ohtsuka. (2006). Body mass index and lung cancer risk in never smokers. Radiology and Oncology. 40(4). 4 indexed citations
7.
Satoh, Hiroaki, et al.. (2006). Prospective Study of Fever and Pneumonia After Flexible Fiberoptic Bronchoscopy in Older People. Journal of the American Geriatrics Society. 54(5). 827–830. 25 indexed citations
8.
Kurishima, Koichi, Hiroaki Satoh, Shinsuke Homma, et al.. (2005). Multiple primary malignancies in patients with lung cancer. Radiology and Oncology. 39(1). 5 indexed citations
9.
Satoh, Hiroaki, Morio Ohtsuka, & Kiyohisa Sekizawa. (2005). Chemotherapy for mediastinal germ cell tumor before definitive pathologic diagnosis. International Journal of Clinical Practice. 59(147). 99–99. 1 indexed citations
10.
Satoh, Hiroaki, Morio Ohtsuka, & Kiyohisa Sekizawa. (2003). Endobronchial Actinomycosis and Foreign Body. CHEST Journal. 123(2). 656–657. 3 indexed citations
11.
Kagohashi, Katsunori, Hiroaki Satoh, Hiroichi Ishikawa, Morio Ohtsuka, & Kiyohisa Sekizawa. (2003). BONE METASTASIS AS THE FIRST MANIFESTATION OF LUNG CANCER. International Journal of Clinical Practice. 57(3). 184–186. 16 indexed citations
12.
Satoh, Hiroaki, Hiroichi Ishikawa, Morio Ohtsuka, & Kiyohisa Sekizawa. (2002). Spontaneous regression of pulmonary bullae. Australasian Radiology. 46(1). 106–107. 2 indexed citations
13.
Kurishima, Koichi, et al.. (2001). Lung Cancer in the Octogenarian. Gerontology. 47(3). 158–160. 7 indexed citations
14.
Ishikawa, Hiroichi, Hiroaki Satoh, Y. Yamashita, et al.. (1998). Curved chest tube for drainage of malignant pleural effusion. Respiratory Medicine. 92(4). 633–637. 4 indexed citations
15.
Ishikawa, Hiroichi, Hiroaki Satoh, S Hasegawa, et al.. (1997). Urokinase-type plasminogen activator in carcinomatous pleural fluid. European Respiratory Journal. 10(7). 1566–1571. 9 indexed citations
16.
Ishikawa, Hiroichi, Hiroaki Satoh, Takashi Naito, et al.. (1996). Lung Cancer in Ibaraki Prefecture: Summary of Clinical Assessment in 1100 Cases, with Special Reference to The Reasons for Detection of the Cancer.. Haigan. 36(7). 885–891. 1 indexed citations
17.
Yoshizawa, Yasuyuki, T. Sato, Hiroichi Ishikawa, et al.. (1995). A Compartmentalized Bias for T-Cell Receptor Vβ Usage in Summer-Type Hypersensitivity Pneumonitis. International Archives of Allergy and Immunology. 107(4). 581–586. 4 indexed citations
18.
Ohtsuka, Morio, et al.. (1994). The Motility of Lung Lymphocytes in Hypersensitivity Pneumonitis and Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 149(2). 455–459. 11 indexed citations
19.
Sato, T., et al.. (1993). Pulmonary Alveolar Proteinosis Xe-133 Scintigraphic Findings Before and After Bronchopulmonary Lavage. Clinical Nuclear Medicine. 18(2). 123–125. 4 indexed citations
20.
Yoshizawa, Yasuyuki, et al.. (1991). Sequential changes in lung injury induced by preformed immune complexes. Clinical Immunology and Immunopathology. 61(3). 376–386. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masahiro Tominaga Breakdown of academic impact, for papers by Kimo C. Stine Breakdown of academic impact, for papers by Jiro Usuki Breakdown of academic impact, for papers by David G. Morris Breakdown of academic impact, for papers by B Gosselin Breakdown of academic impact, for papers by Anne Marfaing‐Koka Breakdown of academic impact, for papers by Marie‐Noelle Péraldi Breakdown of academic impact, for papers by Koichiro Nakata Breakdown of academic impact, for papers by M.C. Copin Breakdown of academic impact, for papers by Y Fukuda
Rankless by CCL
2026